172 related articles for article (PubMed ID: 22454423)
1. Genetic variations and patient-reported quality of life among patients with lung cancer.
Sloan JA; de Andrade M; Decker P; Wampfler J; Oswold C; Clark M; Yang P
J Clin Oncol; 2012 May; 30(14):1699-704. PubMed ID: 22454423
[TBL] [Abstract][Full Text] [Related]
2. Systematic evaluation of genetic variants in three biological pathways on patient survival in low-stage non-small cell lung cancer.
Pankratz VS; Sun Z; Aakre J; Li Y; Johnson C; Garces YI; Aubry MC; Molina JR; Wigle DA; Yang P
J Thorac Oncol; 2011 Sep; 6(9):1488-95. PubMed ID: 21792076
[TBL] [Abstract][Full Text] [Related]
3. Candidate pathway-based genetic association study of platinum and platinum-taxane related toxicity in a cohort of primary lung cancer patients.
Johnson C; Pankratz VS; Velazquez AI; Aakre JA; Loprinzi CL; Staff NP; Windebank AJ; Yang P
J Neurol Sci; 2015 Feb; 349(1-2):124-8. PubMed ID: 25586538
[TBL] [Abstract][Full Text] [Related]
4. Aberrant promoter methylation of CDH13 and MGMT genes is associated with clinicopathologic characteristics of primary non-small-cell lung carcinoma.
Kontic M; Stojsic J; Jovanovic D; Bunjevacki V; Ognjanovic S; Kuriger J; Puumala S; Nelson HH
Clin Lung Cancer; 2012 Jul; 13(4):297-303. PubMed ID: 22169480
[TBL] [Abstract][Full Text] [Related]
5. Methylation status of O6-methylguanine-DNA-methyl transferase promoter region in non-small-cell lung cancer patients with brain metastasis.
Hashimoto K; Narita Y; Matsushita Y; Miyakita Y; Ono M; Kayama T; Shibui S
Clin Transl Oncol; 2012 Jan; 14(1):31-5. PubMed ID: 22262716
[TBL] [Abstract][Full Text] [Related]
6. The A/G allele of rs16906252 predicts for MGMT methylation and is selectively silenced in premalignant lesions from smokers and in lung adenocarcinomas.
Leng S; Bernauer AM; Hong C; Do KC; Yingling CM; Flores KG; Tessema M; Tellez CS; Willink RP; Burki EA; Picchi MA; Stidley CA; Prados MD; Costello JF; Gilliland FD; Crowell RE; Belinsky SA
Clin Cancer Res; 2011 Apr; 17(7):2014-23. PubMed ID: 21355081
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of glutathione metabolic genes on outcomes in advanced non-small cell lung cancer patients after initial treatment with platinum-based chemotherapy: an NCCTG-97-24-51 based study.
Yang P; Mandrekar SJ; Hillman SH; Allen Ziegler KL; Sun Z; Wampfler JA; Cunningham JM; Sloan JA; Adjei AA; Perez E; Jett JR
J Thorac Oncol; 2009 Apr; 4(4):479-85. PubMed ID: 19347979
[TBL] [Abstract][Full Text] [Related]
8. Genetic variants in genes of tricarboxylic acid cycle key enzymes are associated with prognosis of patients with non-small cell lung cancer.
Guo X; Li D; Wu Y; Chen Y; Zhou X; Wang X; Huang X; Li X; Yang H; Xing J
Lung Cancer; 2015 Feb; 87(2):162-8. PubMed ID: 25576295
[TBL] [Abstract][Full Text] [Related]
9. MGMT methylation is associated primarily with the germline C>T SNP (rs16906252) in colorectal cancer and normal colonic mucosa.
Hawkins NJ; Lee JH; Wong JJ; Kwok CT; Ward RL; Hitchins MP
Mod Pathol; 2009 Dec; 22(12):1588-99. PubMed ID: 19734844
[TBL] [Abstract][Full Text] [Related]
10. Genetic variants in MGMT and risk of lung cancer in Southeastern Chinese: a haplotype-based analysis.
Hu Z; Wang H; Shao M; Jin G; Sun W; Wang Y; Liu H; Wang Y; Ma H; Qian J; Jin L; Wei Q; Lu D; Huang W; Shen H
Hum Mutat; 2007 May; 28(5):431-40. PubMed ID: 17285603
[TBL] [Abstract][Full Text] [Related]
11. Genetic variations in epigenetic genes are predictors of recurrence in stage I or II non-small cell lung cancer patients.
Wagner KW; Ye Y; Lin J; Vaporciyan AA; Roth JA; Wu X
Clin Cancer Res; 2012 Jan; 18(2):585-92. PubMed ID: 22252258
[TBL] [Abstract][Full Text] [Related]
12. Correlation of DNA Repair Gene Polymorphisms With Clinical Outcome in Patients With Locally Advanced Non-Small-Cell Lung Cancer Receiving Induction Chemotherapy Followed by Surgery.
Santarpia M; Ramirez JL; de Aguirre I; Garrido P; PĂ©rez Cano M; Queralt C; Gonzalez-Larriba JL; Insa A; Provencio M; Isla D; Camps C; Blanco R; Moran T; Rosell R;
Clin Lung Cancer; 2017 Mar; 18(2):178-188.e4. PubMed ID: 27908619
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms and haplotypes of BRCA1 gene associated with quality of life and survival among patients with non-small-cell lung cancer.
Su T; Sun H; Lu X; He C; Xiao L; He J; Yang Y; Tang Y
Qual Life Res; 2020 Oct; 29(10):2631-2640. PubMed ID: 32424803
[TBL] [Abstract][Full Text] [Related]
14. Genetic variation in glutathione metabolism and DNA repair genes predicts survival of small-cell lung cancer patients.
Sun Z; Chen J; Aakre J; Marks RS; Garces YY; Jiang R; Idowu O; Cunningham JM; Liu Y; Pankratz VS; Yang P
Ann Oncol; 2010 Oct; 21(10):2011-2016. PubMed ID: 20439344
[TBL] [Abstract][Full Text] [Related]
15. The genetic variations in DNA repair genes ERCC2 and XRCC1 were associated with the overall survival of advanced non-small-cell lung cancer patients.
Wang S; Wang J; Bai Y; Wang Q; Liu L; Zhang K; Hong X; Deng Q; Zhang X; He M; Wu T; Xu P; Guo H
Cancer Med; 2016 Sep; 5(9):2332-42. PubMed ID: 27465648
[TBL] [Abstract][Full Text] [Related]
16. Genetic variants of the Wnt signaling pathway as predictors of recurrence and survival in early-stage non-small cell lung cancer patients.
Coscio A; Chang DW; Roth JA; Ye Y; Gu J; Yang P; Wu X
Carcinogenesis; 2014 Jun; 35(6):1284-91. PubMed ID: 24517998
[TBL] [Abstract][Full Text] [Related]
17. Effect of change in symptoms, respiratory status, nutritional profile and quality of life on response to treatment for advanced non-small cell lung cancer.
Mohan A; Singh P; Kumar S; Mohan C; Pathak AK; Pandey RM; Guleria R
Asian Pac J Cancer Prev; 2008; 9(4):557-62. PubMed ID: 19256738
[TBL] [Abstract][Full Text] [Related]
18. Trps1 is associated with the multidrug resistance of lung cancer cell by regulating MGMT gene expression.
Liu H; Liao Y; Tang M; Wu T; Tan D; Zhang S; Wang H
Cancer Med; 2018 May; 7(5):1921-1932. PubMed ID: 29601666
[TBL] [Abstract][Full Text] [Related]
19. CHEK2, MGMT, SULT1E1 and SULT1A1 polymorphisms and endometrial cancer risk.
O'Mara TA; Ferguson K; Fahey P; Marquart L; Yang HP; Lissowska J; Chanock S; Garcia-Closas M; Thompson DJ; Healey CS; Dunning AM; Easton DF; ; Webb PM; Spurdle AB
Twin Res Hum Genet; 2011 Aug; 14(4):328-32. PubMed ID: 21787115
[TBL] [Abstract][Full Text] [Related]
20. Associations between maternal genotypes and metabolites implicated in congenital heart defects.
Chowdhury S; Hobbs CA; MacLeod SL; Cleves MA; Melnyk S; James SJ; Hu P; Erickson SW
Mol Genet Metab; 2012 Nov; 107(3):596-604. PubMed ID: 23059056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]